1. Nateglinide reduces postprandial glucose levels, with a low risk of hypoglycaemia in patients with type 2 diabetes mellitus

   Drugs and Profile Reports 06 January 2013 Pages: 1 - 4

2. Voriconazole in the Treatment of Invasive Aspergillosis: profile report

   • John H. Rex
   • Thomas F. Patterson

   Drugs and Profile Reports 06 January 2013 Pages: 5 - 7

3. Formoterol Delivered by Turbuhaler® in Paediatric Asthma: profile report

   • Fernando M. de Benedictis
   • David Selvaggio
   • Imran Aziz

   Drugs and Profile Reports 06 January 2013 Pages: 8 - 9

4. A multipronged approach needed for successful management of sickle cell anaemia

   Disease Management 06 January 2013 Pages: 10 - 13

5. Cognitive dysfunction is a considerable, yet under-recognised, problem in patients with multiple sclerosis

   Disease Management 06 January 2013 Pages: 13 - 16

6. Vaccination programmes are beating bacterial meningitis but treatment remains a challenge

   Disease Management 06 January 2013 Pages: 17 - 20

7. First reports of adverse drug reactions (ADRs) in recent weeks

   Drug Reactions and Interactions 06 January 2013 Pages: 20 - 21

8. Skin reactions to antidepressants are common, but usually mild and easily treated

   Drug Reactions and Interactions 06 January 2013 Pages: 22 - 26

9. New in the marketplace

   Product Introductions 06 January 2013 Pages: 26 - 26